Zofran Birth Defect Lawyers in St. Louis and Metro-East Illinois

Zofran birth defect lawyers from our firm are currently working with families throughout the St. Louis and Metro-East Illinois area to recover substantial compensation after their child was born with a birth defect linked to Zofran. Zofran is a drug designed to reduce nausea in chemotherapy patients, but which has also been prescribed to treat severe morning sickness. Unfortunately, many mothers were not warned that Zofran during pregnancy can cause serious heart defects, cleft lip and cleft palate, and other congenital birth defects.


Serious Zofran Birth Defects

Multiple serious birth defects have been associated with use of Zofran to treat morning sickness. The most common birth defects include oral cleft defects and heart defects.

A study published in Birth Defects Research in 2012 found that babies exposed to Zofran in the womb are 2.4 times more likely to be born with an oral cleft birth defect. Oral cleft defects such as cleft lip and cleft palate are often thought of as cosmetic issues, but can actually cause serious health issues including impaired eating, chronic ear infections, and problems with dental and jaw structure.

A study conducted on more than 900,000 pregnancies by Danish researchers found that women who use Zofran during pregnancy are up to twice as likely to give birth to a child with a serious heart defect. Possibly fatal heart defects linked to Zofran include:

 

  • Atrial septal defects
  • Ventricular septal defects
  • Heart murmur

 

Other birth defects associated with Zofran include webbed feet, skeletal malformations, kidney defects, and fetal growth restriction.


Illegal Marketing of Zofran

Zofran was approved by the FDA to treat nausea in chemotherapy patients and patients recovering from surgery. However, Zofran was never deemed safe by the FDA to use during pregnancy. While it is not illegal for a drug to be prescribed for unapproved, “off-label” purposes, it is against federal law for drugs to be promoted for off-label uses.

In a Department of Justice investigation into illegal marketing of Zofran for off-label use during pregnancy, it was discovered that GlaxoSmithKline was aware of the high risk of birth defects linked to Zofran but that they continued to encourage sales reps to promote Zofran to treat morning sickness. At the conclusion of the investigation in 2012, GlaxoSmithKline was fined $3 billion for illegally promoting off-label use of Zofran and for other violations.


Zofran Lawsuit Consultations in St. Louis and Metro-East Illinois

If you live in St. Louis, Metro-East Illinois or surrounding communities and believe your child’s birth defect or defects may be linked to use of Zofran during pregnancy, you could be entitled to compensation that will help you secure the best possible care for that child. Please contact us today to learn more about Zofran birth defect lawsuits in a free legal consultation.